Total Synthesis and Antitubulin Activity of C10 Analogues of Cryptophycin-24

Journal of Medicinal Chemistry

Volumn 47, Issue 3, 2004, Pages 696-702

  Buck, Suzanne B ^a   Huff, Jacquelyn K ^a   Himes, Richard H ^a   Georg, Gunda I ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARENASTATIN A; COLCHICINE; MAYTANSINE; PACLITAXEL; RHIZOXIN; TUBULIN; VINBLASTINE;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; CRYPTOCOCCUS; CYTOTOXICITY; DOSE RESPONSE; DRUG STRUCTURE; DRUG SYNTHESIS; FUNGICIDAL ACTIVITY; HUMAN; HUMAN CELL; MICROTUBULE ASSEMBLY; MULTIDRUG RESISTANCE; NOSTOC; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DEPSIPEPTIDES; HUMANS; PEPTIDES, CYCLIC; STRUCTURE-ACTIVITY RELATIONSHIP; TUBULIN MODULATORS;

EID: 1642540539     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030278c     Document Type: Article

References (35)

1. Tius, M. A. Synthesis of the Cryptophycins. Tetrahedron 2002, 58, 4343-4367.
2. Shih, C.; Al-Awar, R. S.; Fray, A. H.; Martinelli, M. J.; Moher, E. D.; Norman, B. H.; Patel, V. F.; Schultz, R. M.; Toth, J. E.; Varie, D. L.; Corbett, T. H.; Moore, R. E. Synthesis and Structure-Activity Relationship Studies of Cryptophycins: a Novel Class of Potent Antimitotic Antitumor Depsipeptides. In Anticancer Agents; Ojima, I., Vite, G. D., Altmann, K.-H., Eds.; American Chemical Society: Washington, D. C., 2001; pp 171-189.
3. Shih, C.; Teicher, B. A. Cryptophycins: a Novel Class of Potent Antimitotic Antitumor Depsipeptides. Curr. Pharm. Des. 2001, 7, 1259-1276.
4. Eggen, M.; Georg, G. I. The Cryptophycins: Their Synthesis and Anticancer Activity. Med. Res. Rev. 2002, 22, 85-101.
5. Schwartz, R. E.; Hirsch, C. F.; Sesin, D. F.; Flor, J. E.; Chartrain, M. ; Fromtling, R. E.; Harris, G. H.; Salvatore, M. J.; Liesch, J. M.; Yudin, K. Pharmaceuticals From Cultured Algae. J. Ind. Microbiol. 1990, 5, 113-124.
6. Trimurtulu, G.; Ohtani, I.; Patterson, G. M. L.; Moore, R. E.; Corbett, T. H.; Valeriote, F. A.; Demchik, L. Total Structures of Cryptophycins, Potent Antitumor Depsipeptides from the Blue-Green Alga Nostoc sp. Strain GSV 224. J. Am. Chem. Soc. 1994, 116, 4729-4737.
7. Subbaraju, G. V.; Golakoti, T.; Patterson, G. M. L.; Moore, R. E. Three New Cryptophycins from Nostoc sp. GSV 224. J. Nat. Prod. 1997, 60, 302-305.
8. Corbett, T. H.; Valeriote, F. A.; Demchik, L.; Polin, L.; Panchapor, C.; Pugh, S.; White, K.; Knight, J.; Jones, J.; Jones, L.; LoRusso, P.; Foster, B.; Wiegand, R. A.; Lisow, L.; Golakoti, T.; Heltzel, C. E.; Ogino, J.; Patterson, G. M.; Moore, R. E. Preclinical Anticancer Activity of Cryptophycin-8. J. Exp. Ther. Oncol. 1996, 1, 95-108.
9. Barrow, R. A.; Hemscheidt, T.; Liang, J.; Paik, S.; Moore, R. E.; Tius, M. A. Total Synthesis of Cryptophycins. Revision of the Structures of Cryptophycin A and C. J. Am. Chem. Soc. 1995, 117, 2479-2490.
10. Smith, C. D.; Zhang, X.; Mooberry, S. L.; Patterson, G. M. L.; Moore, R. E. Cryptophycin: A New Antimicrotubule Agent Active Against Drug-Resistant Cells. Cancer Res. 1994, 54, 3779-3784.
11. Kobayashi, M.; Aoki, S.; Ohyabu, N.; Kuroso, M.; Wang, W.; Kitigawa, I. Arenastatin A, a Potent Cytotoxic Depsipeptide From the Okinawa Marine Sponge Dysidea Arenaria. Tetrahedron Lett. 1994, 35, 7969-7972.
12. Morita, K.; Koiso, Y.; Hashimoto, Y.; Kobayashi, M.; Wang, W.; Ohyabu, N.; Iwasaki, S. Interaction of Arenastatin A with Porcine Brain Tubulin. Biol. Pharm. Bull. 1997, 20, 171-174.
13. Patel, V. F.; Andis, S. L.; Kennedy, J. H.; Ray, J. E.; Schultz, R. M. Novel Cryptophycin Antitumor Agents: Synthesis and Cytotoxicity of Fragment "B" Analogues. J. Med. Chem. 1999, 42, 2588-2603.
14. Wagner, M. M.; Paul, D. C.; Shih, C.; Jordan, M. A.; Wilson, L.; Williams, D. C. In Vitro Pharmacology of Cryptophycin 52 (LY355703) in Human Tumor Cell Lines. Cancer Chemother. Pharmacol. 1999, 43, 115-125.
15. Smith, C. D.; Zhang, X. Mechanism of Action of Cryptophycin. Interaction With the Vinca Alkaloid Domain of Tubulin. J. Biol. Chem. 1996, 271, 6192-6198.
16. Mooberry, S. L.; Taoka, C. R.; Busquets, L. Cryptophycin 1 Binds to Tubulin at a Site Distinct From the Colchicine Binding Site and at a Site That May Overlap the Vinca Binding Site. Cancer Lett. 1996, 107, 53-57.
17. Bai, R.; Schwartz, R. E.; Kepler, J. A.; Pettit, G. R.; Hamel, E. Charachterization of the Interaction of Cryptophycin 1 with Tubulin: Binding in the Vinca Domain, Competitive Inhibition of Dolastatin 10 Binding, and an Unusual Aggregation Reaction. Cancer Res. 1996, 56, 6, 4398-4406.
18. Kerksiek, K.; Mejillano, M. R.; Schwartz, R. E.; Georg, G. I.; Himes, R. H. The Interaction of Cryptophycin 1 with Tubulin and Microtubules. FEBS Lett. 1995, 377, 59-61.
19. Lu, K.; Dempsey, J.; Schultz, R. M.; Shih, C.; Teicher, B. A. Cryptophycin-Induced Hyperphosphorylation of Bcl-2, Cell Cycle Arrest and Growth Inhibition in Human H460 NSCLC Cells. Cancer Chemother. Pharmacol. 2001, 47, 170-178.
20. Mooberry, S. L.; Busquets. L.; Tien, G. Induction of Apoptosis by Cryptophycin 1, a New Antimicrotubule Agent. Intl. J. Cancer 1997, 73, 440-448.
21. Kessel, D.; Luo, Y. Cells in Cryptophycin-Induced Cell-Cycle Arrest are Susceptible to Apoptosis. Cancer Lett. 2000, 151, 25-29.
22. Jordan, M. A. Mechanism of Action of Antitumor Drugs that Interact with Microtubules and Tubulin. Curr. Med. Chem. 2002, 2, 1-17.
23. Panda, D.; DeLuca, K.; Williams, D.; Jordan, M. A.; Wilson L. Antiproliferative Mechanism of Action of Cryptophycin-52: Kinetic Stabilization of Microtubule Dynamics by High-Affinity Binding to Microtubule Ends. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 9313-9318.
24. Panda, D.; Himes, R. H.; Moore, R. E.; Wilson, L.; Jordan, M. A. Mechanism of Action of the Unusually Potent Microtubule Inhibitor Cryptophycin 1. Biochemistry 1997, 36, 12948-12953.
25. Teicher, B. A.; Forler, P.; Menon, K.; Phares, V.; Amsrud, T.; Shih, C. Cryptophycin 52 and Cryptophycin 55 in Sequential and Simultaneous Combination Treatment Regimens in Human Tumor Xenografts. In Vivo 2000, 14, 471-480.
26. Menon, K.; Alvarez, E.; Forler, P.; Phares, V.; Amsrud, T.; Shih, C.; Al-Awar, R.; Teicher, B. A. Antitumor Activity of Cryptophycins: Effect of Infusion Time and Combination Studies. Cancer Chemother. Pharmacol. 2000, 46, 142-149.
27. Golakoti, T.; Ogino, J.; Heltzel, C. E.; Husebo, T. L.; Jensen, C. M.; Larsen, L. K.; Patterson, G. M. L.; Moore, R. E.; Mooberry, S. L.; Corbett, T. H.; Valeriote, F. A. Structure Determination, Conformational Analysis, Chemical Stability Studies, and Antitumor Evaluation of 18 New Analogues from Nostoc sp. Strain GSV 224. J. Am. Chem. Soc. 1995, 117, 7, 12030-12049.
28. Eggen, M.; Mossman, C. J.; Buck, S. B.; Nair, S. K.; Bhat, L.; Ali, S. M.; Reiff, E. A.; Boge, T. C.; Georg, G. I. Total Synthesis of Cryptophycin-24 (Arenastatin A) Amenable to Structural Modifications in the C16 Side Chain. J. Org. Chem. 2000, 65, 7792-7799.
29. Eggen, M.; Georg, G. I. Enantioselective Synthesis of a 3′-Dephenylcryptophycin Synthon. Bioorg. Med. Chem. Lett. 1998, 8, 3177-3180.
30. White, J. D.; Hong, J.; Robarge, L. A. Total Synthesis of Cryptophycins-1, -3, -4, -24 (Arenastatin A), and -29, Cytotoxic Depsipeptides from Cyanobacteria of the Nostocaceae. J. Org. Chem. 1999, 64, 6206-6216.
31. Rej, R.; Nguyen, D.; Go, B.; Fortin, S.; Lavallell, J.-F. Total Synthesis of Cryptophycins and their 16-(3-Phenylacryloyl) Derivatives. J. Org. Chem. 1996, 61, 6289-6295.
32. Adam, W.; Bialas, J.; Hadjiarapoglou, L. A. Convenient Preparation of Acetone Solutions of Dimethyldioxirane. Chem. Ber. 1991, 124, 2377.
33. Vidya, R.; Eggen, M.; Georg, G. I.; Himes, R. H. Cryptophycin Affinity Labels: Synthesis and Biological Activity of a Benzophenone Analogue of Cryptophycin- 24. Bioorg. Med. Chem. Lett. 2003, 13, 757-760.
34. Bradford, M. M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal. Biochem. 1976, 72, 248-254.
35. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.